Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
children
infants injection adults at risk |
| gptkbp:alternativeTo |
gptkb:Oral_Poliovirus_Vaccine
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:compatibleWith |
vaccine-derived poliovirus infection
|
| gptkbp:contains |
inactivated (killed) poliovirus
|
| gptkbp:developedBy |
gptkb:Jonas_Salk
|
| gptkbp:features |
immunocompromised individuals
|
| gptkbp:fullName |
gptkb:Inactivated_Poliovirus_Vaccine
|
| https://www.w3.org/2000/01/rdf-schema#label |
IPV
|
| gptkbp:includedIn |
Global Polio Eradication Initiative
|
| gptkbp:introducedIn |
1955
|
| gptkbp:recommendation |
gptkb:World_Health_Organization
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous |
| gptkbp:sideEffect |
mild pain at injection site
|
| gptkbp:storage |
refrigeration required
|
| gptkbp:usedFor |
prevention of poliomyelitis
|
| gptkbp:usedIn |
routine immunization schedules
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:DTaP
gptkb:Pentacel |
| gptkbp:bfsLayer |
6
|